PREPRINT (not peer reviewed)

Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: bioRxiv
Date: 2025-05-30
Source: bioRxiv
DOI: 10.1101/2025.05.26.655791
PubMed: Unavailable

Authors

Joseph K Collins J Genovese T Maxwell M Lieberman JA Osten P.

Watch author

Derived topics and classifications

psilocybin Depression Neuroplasticity Mechanism of Action Receptor Pharmacology Biomarkers Microdosing Animal Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot StudyClinicalTrials.gov · 2026-06-23 Optimizing Microdosing and MeditationClinicalTrials.gov · 2025-06-05